Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
We are recruiting adults aged at least 18 years with a confirmed diagnosis of
Cold Agglutinin Disease (CAD) to voluntarily take part in a study of 4 weeks
dosing of a study drug known as GL-0719 which is being developed for the
treatment of CAD.
ClinicalTrials.gov is a database of privately and publicly funded clinical studies conducted around the world. The safety and scientific validity of these studies is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the CADF Foundation. Please review our Privacy and Policies for more information.
Copyright © 2022 Cold Agglutinin Disease Foundation - All Rights Reserved.
Contact Us: info@cadfadvocacy.org